Literature DB >> 3596636

Characterization of a factor in leprosy serum that inhibits the growth of mitogen-stimulated normal human lymphocytes.

M A Kerr, Y M Hussein, R C Potts, J S Beck, M M Sheriff.   

Abstract

A factor that inhibits the growth of mitogen-stimulated lymphocytes from normal donors has been detected in the sera of patients with chronic leprosy. The inhibitory activity was detected with similar frequency in patients with tuberculoid or lepromatous leprosy, although higher levels of activity were detected in the latter. The factor reduced the growth in volume of the lymphocytes in the first 24 hr after stimulation, the synthesis of RNA during the first 3 days of culture and the replication of DNA in 72-hr cultures. All the inhibitory activity co-purified with IgG on gel filtration, ammonium sulphate fractionation and ion exchange chromatography. The activity was stable to heating at 56 degrees but labile at 100 degrees and was absorbed from serum or from purified IgG preparations by staphylococcal protein A. On gel filtration of the sera on Sephadex G-200, none of the activity appeared in the void volume, indicating that it is not due to immune complexes. We conclude that the activity is due to an IgG antibody and suggest that it is an autoantibody since the sera inhibited the growth of all donor lymphocytes tested.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3596636      PMCID: PMC1453385     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  28 in total

1.  Lumphocytotoxins in leprosy.

Authors:  J M Kreisler; A Arnaiz; B Perez; A Bootello
Journal:  Int J Lepr Other Mycobact Dis       Date:  1975 Apr-Jun

2.  L.E. CELLS AND ANTINUCLEAR FACTORS IN LEPROSY.

Authors:  L BONOMO; A TURSI; G TRIMIGLIOZZI; F DAMMACCO
Journal:  Br Med J       Date:  1965-09-18

3.  Rheumatoid-factor-like substance and antistreptolysin O antibody in leprosy serum. Significance in erythema nodosum leprosum.

Authors:  M Abe; S Chinone; T Hirako
Journal:  Int J Lepr Other Mycobact Dis       Date:  1967 Jul-Sep

4.  Influence of chemotherapy and serum factors on the mitogenic response of peripheral leucocytes of leprosy patients to phytohaemagglutinin.

Authors:  V L Mehra; G P Talwar; K Balakrishnan; L K Bhutani
Journal:  Clin Exp Immunol       Date:  1972-10       Impact factor: 4.330

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Phytohaemagglutinin-induced lymphocyte transformation in leprosy.

Authors:  D S Nelson; M Nelson; J M Thurston; M F Waters; J M Pearson
Journal:  Clin Exp Immunol       Date:  1971-07       Impact factor: 4.330

7.  Studies of immune mechanisms in leprosy. 3. The role of cellular and humoral factors in impairment of the in vitro immune response.

Authors:  W E Bullock; P Fasal
Journal:  J Immunol       Date:  1971-04       Impact factor: 5.422

Review 8.  Immunological phenomena in leprosy and related diseases.

Authors:  J L Turk; A D Bryceson
Journal:  Adv Immunol       Date:  1971       Impact factor: 3.543

9.  Classification of leprosy according to immunity. A five-group system.

Authors:  D S Ridley; W H Jopling
Journal:  Int J Lepr Other Mycobact Dis       Date:  1966 Jul-Sep

10.  Depressive effect of serum from patients with leprosy on mixed lymphocyte reactions. Influence of anti-leprosy treatment.

Authors:  D S Nelson; J M Penrose; M F Waters; J M Pearson; M Nelson
Journal:  Clin Exp Immunol       Date:  1975-12       Impact factor: 4.330

View more
  4 in total

1.  Antigen-specific B-cell unresponsiveness induced by chronic Mycobacterium avium subsp. paratuberculosis infection of cattle.

Authors:  W R Waters; J R Stabel; R E Sacco; J A Harp; B A Pesch; M J Wannemuehler
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

2.  Tuberculous anergic sera or purified protein derivative treatment induces modification in lymphocyte transformation of cells from patients with tuberculosis.

Authors:  H Mejia-López; O Vaca-García; J M Cristerna-Aguirre; A Cruz-Chávez; M Selman-Lama; M L Taylor
Journal:  J Clin Microbiol       Date:  1990-02       Impact factor: 5.948

3.  Cytogenetic studies in leprosy patients before and after chemotherapy.

Authors:  D D'Souza; B C Das; I M Thomas
Journal:  Hum Genet       Date:  1991-10       Impact factor: 4.132

4.  The mechanism of action of the factor in leprosy serum that inhibits the growth of mitogen-stimulated normal human lymphocytes.

Authors:  Y M Hussein; M A Kerr; J S Beck
Journal:  Immunology       Date:  1987-06       Impact factor: 7.397

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.